Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-033763
Filing Date
2017-05-18
Accepted
2017-05-18 20:40:22
Documents
1
Period of Report
2017-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4063
  Complete submission text file 0001209191-17-033763.txt   5513
Mailing Address 8 EAST 67TH STREET NEW YORK NY 10021
Business Address
LEVANDE ROBERT (Reporting) CIK: 0001240092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37744 | Film No.: 17856250

Mailing Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010
Business Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010 650-697-3939
Pulse Biosciences, Inc. (Issuer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: NV | Fiscal Year End: 1217
SIC: 3841 Surgical & Medical Instruments & Apparatus